| High-throughput in vivo mapping of RNA accessible interfaces to identify functional sRNA binding sites MK Mihailovic, J Vazquez-Anderson, Y Li, V Fry, P Vimalathas, D Herrera, ... Nature communications 9 (1), 4084, 2018 | 33 | 2018 |
| Integrin αM activation and upregulation on esophageal eosinophils and periostin‐mediated eosinophil survival in eosinophilic esophagitis P Vimalathas, A Farris, D Letner, V Deshpande, V Yajnik, W Shreffler, ... Immunology and Cell Biology 96 (4), 426-438, 2018 | 15 | 2018 |
| CYP2C19 loss-of-function is associated with increased risk of ischemic stroke after transient ischemic attack in intracranial atherosclerotic disease PD Patel, P Vimalathas, X Niu, CN Shannon, JC Denny, JF Peterson, ... Journal of Stroke and Cerebrovascular Diseases 30 (2), 105464, 2021 | 14 | 2021 |
| Tissue eosinophils express the IL‐33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis AM Uchida, PJ Lenehan, P Vimalathas, KC Miller, M Valencia‐Yang, ... Allergy 77 (2), 656-660, 2022 | 10 | 2022 |
| The IL-33 receptor ST2 is highly induced on IL-13-expressing tissue eosinophils in eosinophilic esophagitis A Uchida, P Vimalathas, MV Yang, K Miller, J Garber Journal of Allergy and Clinical Immunology 145 (2), AB43, 2020 | 1 | 2020 |
| 877-α4β7 Integrin is Dynamically Expressed in Eosinophilic Esophagitis and Mediates Eosinophil Transendothelial Migration P Vimalathas, DM Morgan, H Khalili, JJ Garber Gastroenterology 154 (6), S-175, 2018 | 1 | 2018 |
| An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission J Ding, JJ Garber, A Uchida, A Lefkovith, GT Carter, P Vimalathas, ... Nature Communications 15 (1), 3344, 2024 | | 2024 |
| Evolving Management of Iatrogenic Upper Extremity Pseudoaneurysms: 30-Year Experience of a Single Quaternary Care Center PA Stone, P Vimalathas, L Janda Journal of the American College of Surgeons 237 (Vascular Surgery), S583-S619, 2023 | | 2023 |
| Insurance delay increases IBD disease activity A Zuckerman, N Shah, J DeClercq, L Cherry, P Vimalathas, B Pabla, ... CURRENT MEDICAL RESEARCH AND OPINION 38, 34-34, 2022 | | 2022 |
| Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease N Shah, L Cherry, A Zuckerman, P Vimalathas, L Choi, CA Donoho, ... AMERICAN JOURNAL OF GASTROENTEROLOGY 116, S385-S385, 2021 | | 2021 |
| Fr204 THE IL-33 RECEPTOR ST2 IS EXPRESSED ON IL-13+ TISSUE EOSINOPHILS IN EOSINOPHILIC ESOPHAGITIS AM Uchida, P Lenehan, P Vimalathas, KC Miller, M Valencia-Yang, ... Gastroenterology 160 (6), S-265-S-266, 2021 | | 2021 |
| Pharmacogenomics in Intracranial Atherosclerotic Disease: CYP2C19 Loss-Of-Function is Associated with Increased Risk of First-time Ischemic Stroke PD Patel, P Vimalathas, X Niu, C Shannon, J Peterson, M Fusco, ... Neurosurgery 67 (Supplement_1), 2020 | | 2020 |
| 863 THE IL-33 RECEPTOR ST2 IS HIGHLY INDUCED ON IL-13 EXPRESSING TISSUE EOSINOPHILS IN EOSINOPHILIC ESOPHAGITIS AM Uchida, MV Yang, P Vimalathas, KC Miller, JJ Garber Gastroenterology 158 (6), S-177, 2020 | | 2020 |
| 462-Single-Cell RNA-Sequencing Reveals Distinct Esophageal Epithelial Subsets Specific to Eosinophilic Esophagitis P Vimalathas, DB Graham, R Xavier, JJ Garber Gastroenterology 154 (6), S-107-S-108, 2018 | | 2018 |
| Tu1125 EOSINOPHIL INTEGRIN αM (CD11B/MAC-1) PROMOTES EOSINOPHILIC ESOPHAGITIS THROUGH INTERACTION WITH EPITHELIAL-DERIVED PERIOSTIN A Farris, D Letner, P Vimalathas, V Deshpande, V Yajnik, WG Shreffler, ... Gastroenterology 152 (5), S870-S871, 2017 | | 2017 |
